Medical use is a specific context
The inspected injection label identifies drug-induced methemoglobinemia as its use. It does not establish the benefit of retail oral drops for healthy people. Route, formulation, indication and medical supervision are part of the evidence, not details that can be discarded when comparing products. [1]
Purity does not remove pharmacological risks
The label warns of potentially fatal serotonin syndrome with serotonergic medicines and advises avoiding use in G6PD deficiency because of hemolysis and paradoxical methemoglobinemia. These warnings make a medication review essential. A laboratory purity percentage cannot establish personal suitability or a safe self-treatment regimen. [1]
A comparison needs more than a laboratory certificate
Imagine two brands display certificates but neither supplies a controlled human trial matching its wellness claim. The certificates address selected quality measurements, not comparative benefit. Ask a pharmacist or clinician about the reason for use and exact formulation; do not substitute research or industrial material for a medical product. [2][1]
| Claim | What it establishes |
|---|---|
| Mechanism or product name | A question to investigate |
| Matching human outcome | Evidence needed for a benefit claim |
| Individual suitability | Requires the actual formulation and context |
Sources for this article
- Methylene Blue Injection, USP 1%
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product. - Questions and Answers on Dietary Supplements | FDA
Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.